Advancing Menopause Care and Mid-Life Women’s Health Act
SB4503, the Advancing Menopause Care and Mid-Life Women’s Health Act, would create a broad federal initiative to improve research, education, training, and care delivery related to perimenopause, menopause, and postmenopausal health. The bill directs the National Institutes of Health and the Department of Health and Human Services to expand research on the physical, mental, cognitive, oral, and behavioral health effects of menopause, including disparities affecting rural women and other underserved populations. It also calls for new research categories, translational research, and public health surveillance tools, including a dashboard to track menopausal symptoms and mid-life health outcomes.
The bill further establishes public health promotion and prevention programs, a national awareness and outreach campaign, and grant programs to support early detection, diagnosis, treatment, and care coordination. It authorizes training programs for physicians, nurses, pharmacists, dentists, physician assistants, and other health professionals, and creates Centers of Excellence in Menopause and Mid-Life Women’s Health to develop and distribute evidence-based resources. The legislation also requires HHS to report regularly to Congress on progress, barriers to care, disparities, and recommendations, and to coordinate with other federal agencies such as the VA and Department of Defense.
If enacted, the bill would amend the Public Health Service Act to add new federal authorities and programs focused specifically on menopause and mid-life women’s health. It would expand NIH and HHS research responsibilities, create new grant and training pathways, and require federal reporting and coordination across agencies. The bill authorizes appropriations of $25 million annually for research activities and $10 million annually each for public health promotion, awareness, and training programs for fiscal years 2027 through 2031, with additional sums authorized for the Centers of Excellence and reporting provisions.
The available context suggests generally positive and bipartisan support for the bill’s goals, as reflected in its introduction by a large group of senators from both parties and across ideological lines. The bill’s framing emphasizes improving care, reducing disparities, and addressing a long-overlooked women’s health issue, which indicates a constructive and policy-focused sentiment. No committee debate or recorded votes are provided, so there is no evidence in the supplied materials of formal opposition or amendment activity.
No specific points of contention are documented in the provided transcript or voting history, because no committee discussion or votes are included. Potential areas that could draw scrutiny, based on the text, include the scope of new federal spending, the creation of new reporting and coordination requirements, the use of AI-related diagnostic tools, and how grants and centers of excellence would be distributed between rural and urban areas. The bill also places emphasis on disparities, underserved communities, and culturally appropriate outreach, which may affect how implementation priorities are set.